Kyras Therapeutics
Latest round
- Series A
Last raised
- Dec 2015
Total raised
- Undisclosed
Investors
- 1
About Kyras Therapeutics
Established in 2015, Kyras Therapeutics, Inc. is based in New York, US and operates as a biotechnology company focused on developing novel small molecules that directly target the RAS family of proteins responsible for incurable cancers and developmental disorders.
Who invested in Kyras Therapeutics
1 investor across 1 round
See all investors in Kyras Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 10, 2015
Amount
Undisclosed
Investors
Questions about Kyras Therapeutics
Who invested in Kyras Therapeutics?
Kyras Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kyras Therapeutics raised?
Kyras Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kyras Therapeutics last raise money?
Kyras Therapeutics's most recent round on record is a Series A, in Dec 2015.
What does Kyras Therapeutics do?
Established in 2015, Kyras Therapeutics, Inc.
Where is Kyras Therapeutics headquartered?
Kyras Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Kyras Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kyras Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kyras Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.